How Much Does a GLP-1 Cost Per Year? The 2026 Total-Cost Breakdown

Almost every GLP-1 ad sells you a monthly number. But you don't take a GLP-1 for a month — obesity medicine is chronic-disease treatment, and the figure that actually hits your bank account is the 12-month total. That number is shaped less by which molecule you pick than by where and how you buy it. This guide breaks down the real annual cost of semaglutide and tirzepatide across every route in 2026, shows why the advertised price is almost never your true cost, and gives you a method to calculate your own yearly total.

The quick answer: what a GLP-1 costs per year in 2026

Across the four main ways to buy, annual cost in 2026 falls into clear bands. Brand-name at cash retail is roughly $11,000–$16,000 a year. Manufacturer self-pay vials (LillyDirect for tirzepatide, NovoCare for semaglutide) cut that to about $4,000–$6,000. Verified compounded versions through telehealth typically total $1,700–$2,400 a year, and the lowest advertised sticker prices reach about $1,200. Same active molecules — a 10x spread in annual cost.

SOURCE · Lilly & Novo Nordisk list pricing, LillyDirect, NovoCare, verified provider pages, compounded median · Jun 23, 2026. Confirm current pricing on each provider's site.

Annual cost by route: tirzepatide

Plotted as a yearly total, the gap between brand retail and verified compounded tirzepatide is roughly $11,000 a year for the same active ingredient. The cash-pay LillyDirect vial sits in the middle — a real saving over retail, but still nearly double a credentialed compounded flat plan.

Annual cost by route: semaglutide

Semaglutide shows the same shape, with an even wider top end — Wegovy at cash retail can exceed $16,000 a year, while a verified compounded flat plan runs under $1,800. NovoCare's self-pay vial narrows the gap but doesn't close it.

The “from-price” trap: why the advertised number isn't your annual cost

Here's the part the sticker price hides. GLP-1 dosing is titrated — you start low and step up every few weeks to a maintenance dose. Many telehealth providers price per dose tier, advertising an eye-catching “from $X” that reflects only the lowest starter dose. As you climb to the maintenance dose you'll actually stay on, the monthly price climbs with you. A flat provider charges one price across the entire titration, so its higher-looking starter number can end up cheaper over a year.

The table below models a realistic 12-month path: a flat plan at $186/mo versus an illustrative tiered plan advertising “from $149” that steps up at each titration stage.

The “cheaper” tiered plan with the lower headline ends the year about $986 more expensive. The starter price told you almost nothing about the annual cost.

Cumulative cost over 12 months: flat vs tiered

Watch where the two lines cross. The tiered plan is genuinely cheaper for the first few months — which is exactly when sign-up decisions are made — then overtakes the flat plan around the maintenance phase and never looks back.

Hidden costs most calculators miss

The monthly medication price is rarely the whole bill. Before you trust any annual estimate, check whether these are included:

• Membership or program fees. Some platforms add a separate monthly or annual membership on top of the medication.
• Consultation and lab fees. Initial visits, follow-ups, or required bloodwork may be billed separately — or bundled. Flat plans that include labs and visits are easier to compare honestly.
• Shipping and “rush” fees. Per-shipment charges add up over 12 deliveries a year.
• Dose-change repricing. On tiered plans, every titration step can trigger a price increase — the core of the from-price trap above.
• Cancellation friction. Auto-renew terms, restocking, or minimum commitments can lock in cost even if you stop. Look for clear refund and cancellation terms.

How to calculate your own 12-month total

Skip the headline number and build the real figure in five steps:

1. Find the maintenance-dose price, not the starter. Ask what you'll pay at the dose you'll actually stay on (often the highest tier).
2. Multiply by 12. That's your base annual medication cost — the only apples-to-apples number across providers.
3. Add the fees. Membership, consults, labs, and shipping for a full year.
4. Add the titration ramp. On tiered plans, add the extra cost of the lower-dose months before maintenance (it's a saving, but smaller than the “from” price implies).
5. Compare totals — then verify credentials. The cheapest legitimate option is the lowest 12-month total from a pharmacy you can verify: licensing, a named prescriber, and third-party testing. Use our verification checklist.

Frequently asked questions

How much does a GLP-1 cost per year without insurance in 2026?

It depends entirely on the route. Brand-name tirzepatide (Mounjaro, Zepbound) or semaglutide (Wegovy, Ozempic) at cash retail runs roughly $11,000–$16,000 per year. Manufacturer cash-pay vials (LillyDirect, NovoCare) fall to about $4,000–$6,000 a year. Verified compounded versions through telehealth typically total $1,700–$2,400 a year, and the cheapest advertised sticker prices reach about $1,200 a year.

Is compounded GLP-1 cheaper than brand-name?

Yes, substantially — usually 80–90% less than brand retail. A verified flat compounded plan can run under $200 a month versus roughly $1,000–$1,350 a month for brand retail. The trade-off is that compounded products are not FDA-approved and quality varies by pharmacy, so credentials matter more than the price tag.

Why is my price higher than the “from” amount the provider advertised?

Advertised “from” prices usually reflect the lowest starter dose. As you titrate up to a maintenance dose, many tiered-pricing providers raise the monthly price at each step, so your real annual cost can be hundreds of dollars above the headline. Flat-priced plans charge the same amount across the full titration.

Does the annual cost go down once I reach my maintenance dose?

Not on a tiered plan — maintenance doses are typically the most expensive tier, so cost tends to rise and then stay high. On a flat plan the monthly price never changes, which is why flat pricing often wins over a full year even when its starter price looks higher.

What is the cheapest legitimate way to get a GLP-1 in 2026?

Compare on true maintenance-dose price and 12-month total rather than the starter price. The lowest fully-credentialed flat option we track is NexLife at $145/mo for semaglutide and $186/mo for tirzepatide; the lowest advertised sticker is around $99/mo. Always confirm pharmacy licensing, a named prescriber, and current pricing on the provider's own page before enrolling.

Sources

• Eli Lilly & Co. list pricing and LillyDirect self-pay vial pricing (Mounjaro, Zepbound). 2026.
• Novo Nordisk list pricing and NovoCare self-pay access (Wegovy, Ozempic). 2026.
• GLP-1 Cost Guide verified provider pricing and compounded-median dataset. See our methodology and price database.
• U.S. FDA. Shortage resolution notices (tirzepatide Dec 2024; semaglutide Feb 2025) and proposal to exclude semaglutide, tirzepatide, and liraglutide from the 503B bulks list, Federal Register, 91 Fed. Reg. 23431 (May 1, 2026); comment period through June 29, 2026.

Educational content, not medical advice. Prices are consolidated from public sources, change frequently, and should be verified directly with each provider before enrolling. Compounded semaglutide and tirzepatide are not FDA-approved and are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. Talk to a licensed clinician before starting, stopping, or changing any medication.